Serum calcium is an independent prognostic factor of overall survival in Mexican patients with multiple myeloma

被引:0
|
作者
Maillet, Daniela [1 ]
Montiel-Cervantes, Laura [1 ]
Padilla-Gonzalez, Ysabel
Sanchez-Cortes, Evelia
Xolotl-Castillo, Moises
Vela-Ojeda, Jorge [1 ]
Reyes-Maldonado, Elba [1 ]
机构
[1] Inst Politecn Nacl, Lab Hematopatol, Mexico City 07738, DF, Mexico
关键词
CD138; Cyclin D1; Prognostic factors; Multiple myeloma; Calcium; STAGING SYSTEM; CELL-GROWTH; CYCLIN D1; INTERLEUKIN-6; BETA-2-MICROGLOBULIN; ABNORMALITIES; FEATURES; PROTEIN;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To evaluate the impact of different prognostic factors that has been suggested to be useful in predicting the survival of patients with multiple myeloma (MM). Materials and methods. A longitudinal prospective study was conducted on 24 adult Mexican patients diagnosed with primary MM. The levels of expression of CD38, CD138 and cyclin D1 were analyzed in plasma cells (PCs) from patients and mononuclear cells from healthy donors. Serum levels of lactate dehydrogenase, creatinine, calcium, beta(2) microglobulin and interleukin-6 (IL-6) as well as hemoglobin and platelet count were taken into consideration. Results. CD138 and cyclin D1 levels in absolute numbers were significantly overexpressed in malignant PCs. A positive correlation was noted between cyclin D1 and CD38 expression levels in malignant PCs. IL-6 and serum calcium were also positively correlated in MM patients. Cyclin D1 overexpression was not associated with better overall survival (OS). Normal calcium levels were associated with better overall survival (OS). Serum calcium was the only variable correlating with better OS in Cox regression analysis. Conclusion. Serum calcium is an independent prognostic factor of OS in a population of Mexican patients with MM.
引用
收藏
页码:17 / 24
页数:8
相关论文
共 50 条
  • [1] Serum calcium is an independent prognostic factor of overall survival in Mexican patients with multiple myeloma (vol 64, pg,17, 2012)
    Maillet, Daniela
    Montiel-Cervantes, Laura
    Padilla-Gonzalez, Ysabel
    Sanchez-Cortes, Evelia
    Xolotl-Castillo, Moises
    Vela-Ojeda, Jorge
    Reyes-Maldonado, Elba
    [J]. REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2012, 64 (05): : 497 - 497
  • [2] SERUM FREE LIGHT CHAINS RATIO: AN INDEPENDENT PROGNOSTIC FACTOR FOR OVERALL SURVIVAL AND PROGRESSION FREE SURVIVAL IN MULTIPLE MYELOMA
    Sobh, M.
    Morisset, S.
    Guilli, T.
    Ducastelle-Lepretre, S.
    Barraco, F.
    Chelghoum, Y.
    Thomas, X.
    Cannas, G.
    Praire, A.
    Labussiere, H.
    Nicolini, F.
    Chapuis-Cellier, C.
    Michallet, M.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 382 - 382
  • [3] Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients
    Rebmann, Vera
    Schuett, Philipp
    Brandhorst, Dieter
    Opalka, Bertram
    Moritz, Thomas
    Nowrousian, Mohammad Reza
    Grosse-Wilde, Hans
    [J]. CLINICAL IMMUNOLOGY, 2007, 123 (01) : 114 - 120
  • [4] Soluble MICA as a prognostic factor for the overall survival and progression-free survival of multiple myeloma patients
    Rebmann, V.
    Schuett, P.
    Brandhorst, D.
    Opalka, B.
    Nowrousian, M. R.
    Moritz, T.
    Grosse-Wilde, H.
    [J]. TISSUE ANTIGENS, 2007, 69 (05): : 390 - 390
  • [5] Circulating proteasome level is an independent prognostic factor for survival in patients with multiple myeloma.
    Jakob, C
    Egerer, K
    Feist, E
    Zavrski, I
    Eucker, J
    Heider, U
    Burmester, G
    Possinger, K
    Kloetzel, PM
    Sezer, O
    [J]. BLOOD, 2004, 104 (11) : 415A - 415A
  • [6] Socioeconomic Status Is an Independent Prognostic Factor for Overall Survival in Patients With Multiple Myeloma: Real-World Data From a Cohort of 223 Patients
    Intzes, Stergios
    Symeonidou, Marianthi
    Zagoridis, Konstantinos
    Bezirgiannidou, Zoe
    Pentidou, Aikaterini
    Vrachiolias, Georgios
    Seimenis, Ioannis
    Kotsianidis, Ioannis
    Spanoudakis, Emmanouil
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (10): : 704 - 711
  • [7] Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma
    Jakob, Christian
    Egerer, Karl
    Liebisch, Peter
    Turkmen, Seval
    Zavrski, Ivana
    Kuckelkorn, Ulrike
    Heider, Ulrike
    Kaiser, Martin
    Fleissner, Claudia
    Sterz, Jan
    Kleeberg, Lorenz
    Feist, Eugen
    Burmester, Gerd-R.
    Kloetzel, Peter-M.
    Sezer, Orhan
    [J]. BLOOD, 2007, 109 (05) : 2100 - 2105
  • [8] Prognostic Nomogram for the Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
    Zhang, Yue
    Chen, Xiao-Lei
    Chen, Wen-Ming
    Zhou, He-Bing
    [J]. BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [9] Is hypercalcemia an independent prognostic factor in Brazilian patients with multiple myeloma?
    Hungria, V.
    Maiolino, A.
    Martinez, G.
    Colleoni, G.
    Coelho, E.
    Rocha, L.
    Nunes, R.
    Bittencourt, R.
    Oliveira, L.
    Faria, R. M.
    Pasquini, R.
    Magalhaes, S.
    Souza, C. A.
    Pinto Neto, J. V.
    Barreto, L.
    Andrade, E.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 203 - 203
  • [10] Socioeconomic Status is Globally a Prognostic Factor for Overall Survival of Multiple Myeloma Patients: Synthesis of Studies and Review of the Literature
    Intzes, Stergios
    Symeonidou, Marianthi
    Zagoridis, Konstantinos
    Bezirgianidou, Zoe
    Vrachiolias, Georgios
    Spanoudaki, Athina
    Spanoudakis, Emmanouil
    [J]. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2021, 13